Sharpe ratio is not yet available for DVXV. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar ETFs
The table compares WEBs Health Care XLV Defined Volatility ETF's Sharpe Ratio with other ETFs in the Health & Biotech Equities category across multiple time periods, showing how DVXV's risk-adjusted performance compares to similar funds.
Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 5, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | 3.49 | |||
| IHE | iShares U.S. Pharmaceuticals ETF | 2.54 | |||
| XBI | SPDR S&P Biotech ETF | 2.45 | |||
| LFSC | F/m Emerald Life Sciences Innovation ETF | 2.43 | |||
| SBIO | ALPS Medical Breakthroughs ETF | 2.35 | |||
| PJP | Invesco Dynamic Pharmaceuticals ETF | 2.34 | |||
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 2.32 | |||
| GNOM | Global X Genomics & Biotechnology ETF | 2.18 | |||
| IBBQ | Invesco Nasdaq Biotechnology ETF | 2.18 | |||
| IBRN | iShares Neuroscience and Healthcare ETF | 2.10 | |||
| DVXV | WEBs Health Care XLV Defined Volatility ETF | — |
Loading charts...
How does DVXV fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio